Literature DB >> 15261428

Epidemiology of malignant mesothelioma in Australia.

A William Musk1, Nicholas H de Klerk.   

Abstract

In Australia, consumption of asbestos peaked in about 1975 at around 70,000t per year--the majority being used for asbestos cement manufacture. Chrysotile, amphibole and crocidolite have all been mined in Australia and employment records from the single company which mined most of the crocidolite deposits at Wittenoom have formed the basis of an ongoing cohort mortality study of the workforce.

Entities:  

Mesh:

Substances:

Year:  2004        PMID: 15261428     DOI: 10.1016/j.lungcan.2004.04.010

Source DB:  PubMed          Journal:  Lung Cancer        ISSN: 0169-5002            Impact factor:   5.705


  10 in total

Review 1.  Lung cancer: Biology and treatment options.

Authors:  Hassan Lemjabbar-Alaoui; Omer Ui Hassan; Yi-Wei Yang; Petra Buchanan
Journal:  Biochim Biophys Acta       Date:  2015-08-19

Review 2.  Guidelines for the diagnosis and treatment of malignant pleural mesothelioma.

Authors:  Nico van Zandwijk; Christopher Clarke; Douglas Henderson; A William Musk; Kwun Fong; Anna Nowak; Robert Loneragan; Brian McCaughan; Michael Boyer; Malcolm Feigen; David Currow; Penelope Schofield; Beth Ivimey Nick Pavlakis; Jocelyn McLean; Henry Marshall; Steven Leong; Victoria Keena; Andrew Penman
Journal:  J Thorac Dis       Date:  2013-12       Impact factor: 2.895

3.  The relationship between tumor MSLN methylation and serum mesothelin (SMRP) in mesothelioma.

Authors:  Heather H Nelson; Lindsay M Almquist; Jessica L LaRocca; Silvia L Plaza; Geralyn M Lambert-Messerlian; David J Sugarbaker; Raphael Bueno; John J Godleski; Carmen J Marsit; Brock C Christensen; Karl T Kelsey
Journal:  Epigenetics       Date:  2011-08-01       Impact factor: 4.528

Review 4.  Surgical biology for the clinician: peritoneal mesothelioma: current understanding and management.

Authors:  Terence C Chua; Tristan D Yan; David L Morris
Journal:  Can J Surg       Date:  2009-02       Impact factor: 2.089

5.  Impact of tumor angiogenesis in peritoneal mesothelioma after radical cytoreduction and hyperthermic intraperitoneal chemotherapy.

Authors:  Terence C Chua; Peng Yao; Javed Akther; David L Morris
Journal:  Pathol Oncol Res       Date:  2009-10-01       Impact factor: 3.201

6.  Mutational analysis of hedgehog signaling pathway genes in human malignant mesothelioma.

Authors:  Chuan Bian Lim; Cecilia M Prêle; Hui Min Cheah; Yuen Yee Cheng; Sonja Klebe; Glen Reid; D Neil Watkins; Svetlana Baltic; Philip J Thompson; Steven E Mutsaers
Journal:  PLoS One       Date:  2013-06-24       Impact factor: 3.240

7.  Wnt7A is a putative prognostic and chemosensitivity marker in human malignant pleural mesothelioma.

Authors:  Tomomi Hirata; Qingfeng Zheng; Zhao Chen; Hiroyasu Kinoshita; Junichi Okamoto; Johannes Kratz; Hui Li; Natalie Lui; Hanh Do; Tiffany Cheng; Hsin-Hui Katty Tseng; Kiyoshi Koizumi; Kazuo Shimizu; Hai-Meng Zhou; David Jablons; Biao He
Journal:  Oncol Rep       Date:  2015-01-29       Impact factor: 3.906

8.  Pleural fluid mesothelin as an adjunct to the diagnosis of pleural malignant mesothelioma.

Authors:  Jenette Creaney; Amanda Segal; Nola Olsen; Ian M Dick; A W Bill Musk; Steven J Skates; Bruce W Robinson
Journal:  Dis Markers       Date:  2014-11-23       Impact factor: 3.434

9.  Clinical nurse specialist role in providing generalist and specialist palliative care: A qualitative study of mesothelioma clinical nurse specialists.

Authors:  Clare Gardiner; Madeleine Harrison; Sarah Hargreaves; Beth Taylor
Journal:  J Adv Nurs       Date:  2022-04-29       Impact factor: 3.057

10.  Identification of novel autoantibodies for detection of malignant mesothelioma.

Authors:  Xufei Zhang; Weike Shen; Xiaomin Dong; Jiangping Fan; Lixia Liu; Xu Gao; Kemp H Kernstine; Li Zhong
Journal:  PLoS One       Date:  2013-08-19       Impact factor: 3.240

  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.